INTRODUCTION
The serine proteinase thrombin has a central and well-established role in haemostasis and coagulation [1] . A less familiar action of thrombin is its potential role as a pro-inflammatory mediator acting on monocyte/macrophages. Studies have shown that thrombin is both chemotactic and mitogenic for human peripheral blood monocytes and various macrophage cell lines [2] [3] [4] . These studies have also shown that the chemotactic and mitogenic effects of thrombin were mediated by catalytically inactive thrombin derivatives such as di-isopropylphosphorofluoridate treated thrombin, N2-tosyl-L-lysine chloromethyl ketone (TLCK)-treated thrombin or D-phenylalanyl-L-prolyl-Larginine chloromethyl ketone (PPACK)-treated thrombin [2, 3] . Furthermore, peptide fragments of the B-chain of thrombin, which are totally devoid of proteinase activity, were chemotactic and mitogenic [2, 3] . Specifically, based on the amino acid sequence data for human prothrombin [5] , a synthetic 14-aminoacid peptide corresponding to thrombin B-chain residues 367-380 was mitogenic, while a peptide fragment corresponding to thrombin B-chain residues 338-400 was both chemotactic and mitogenic [3, 4] .
The studies of Bar-Shavit et al. [2] [3] [4] suggest that activation of human blood monocytes and murine macrophages by thrombin occurs via a hormone-like non-proteolytic receptor-dependent mechanism, thus clearly contrasting with the proteolytic mechanism of thrombin receptor activation operating in platelets, endothelial cells and fibroblasts [6] [7] [8] [9] [10] [11] [12] [13] . The proteolytic mechanism of thrombin receptor activation was recently elucidated following the cDNA cloning of the thrombin receptor present in mitogenic in murine macrophages. Evidence was obtained, however, in U937 cells for the presence of a proteolytic-dependent thrombin receptor similar to the thrombin receptor expressed in platelets, which following thrombin cleavage exposes a new Nterminal tethered ligand. In support of this, a thrombin-receptorderived hexapeptide (TRP; sequence SFLLRN), corresponding to a part of the thrombin receptor tethered ligand, mimicked all the actions ofthrombin in U937 cells. Further, TRP and thrombin cross-desensitized U937 cells to subsequent stimulation with either TRP or thrombin, suggesting that TRP acted through the same U937 cell surface receptor as did thrombin. Thrombin activation of U937 monocytic cells can therefore be accounted for entirely by a proteolytic mechanism of thrombin receptor activation.
DAMI human megakaryoblastic cells and in CCL39 Chinese hamster fibroblasts [6] [7] [8] . A unique feature ofthe cloned thrombin receptor is that receptor activation requires the proteolytic cleavage by thrombin of the N-terminal extracellular domain of the receptor [6] [7] [8] . The newly exposed N-terminal sequence then functions as a tethered ligand which binds to an as yet undefined region of the receptor, resulting in receptor activation. In support of this, a 14-amino-acid synthetic peptide corresponding to a part of the newly created N-terminal thrombin receptor sequence (in the amino acid single letter code, SFLLRNPNDKYEPF and SFFLRNPGENTFEL for the human and hamster thrombin receptors respectively) mimics the ability of thrombin to activate DAMI or CCL39 cells [6] [7] [8] [9] . In addition, the 14-amino-acid peptide has been shown to activate platelets, endothelial cells, fibroblasts and the megakaryoblastic HEL cell line [6] [7] [8] [9] [10] [11] [12] [13] . It follows that thrombin receptor activation in all of these cells requires proteolytic cleavage of the thrombin receptor. More recent structure-activity studies have revealed that the cellular actions of thrombin can be mimicked by a hexapeptide based on the first six residues of the 14-residue thrombin receptor peptide (SFLLRN and SFFLRN for the human and hamster thrombin receptor respectively) [9, 12, 14] .
In the present study we have determined whether the nonproteolytic mechanisms of thrombin receptor activation reported previously in human blood monocytes and murine macrophage cells [2] [3] [4] is common to other monocyte/macrophage cell systems. We have used the U937 human leukaemic monocyte/ macrophage cell line, a well-characterized cell line known to display many of the features of monocytes/macrophages [15] . U937 cells respond to thrombin stimulation with the activation Abbreviations used: TLCK, N'-tosyl-L-lysine chloromethyl ketone (Tos-Lys-CH2CI); PPACK, D-phenylanine-L-prolyl-L-arginine chloromethyl ketone;
[Ca2+]1, intracellular free Ca2+ concentration; TRP, thrombin receptor peptide; NBD, 7-nitrobenz-2-oxa-1,3-diazole; FCS, foetal calf serum.
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of phospholipase C, the mobilization of intracellular Ca2l, actin polymerization and chemotaxis [2, 16, 17] . The presence of a nonproteolytic mechanism was assessed using the inactive thrombin derivative TLCK-thrombin. We have also examined in U937 cells the mitogenic effect of the synthetic 14-amino-acid peptide corresponding to thrombin B-chain residues 367-380 (Peptide 1; YPPWNKNFTENDLL), which was reported to be mitogenic in various murine macrophage cell lines [3, 4] .
The human prothrombin protein sequence of Butkowski et al. [5] , on which Peptide 1 is based, conflicts with other published human prothrombin protein sequences in its amide assignment [18, 19] . In particular, there is an Asn [5] instead of an Asp [18, 19] at position 371 in the thrombin B-chain. Consequently, in the present study we have examined the mitogenic effects of a second 14-amino-acid peptide, which is also based on thrombin B-chain residues 367-380, but with substitution of an Asp for Asn at residue 371 (Peptide 2; YPPWDKNFTENDLL). We have also addressed the question of whether a proteolytic mechanism of thrombin receptor activation operates in U937 cells using the hexapeptide thrombin receptor peptide (TRP; sequence SFLLRN) [12, 14] .
Our results indicate that, in U937 human monocytic cells, thrombin stimulates intracellular Ca2+ mobilization, actin polymerization and mitogenesis by a mechanism solely involving the proteolytic cleavage of the thrombin receptor. Loading of U937 cells with Indo-l/AM has been described elsewhere [16, 17] . The preparation of washed human platelets for [Ca2+] , experiments has also been reported in detail elsewhere [16] , with the exception that in the present study platelets were loaded with 3 ,tM Indo-1/AM. U937 cells or platelets (500,ul samples) were incubated at 37°C with stirring, and the fluorescence levels measured using a Shimadzu RF-5000 spectrofluorophotometer. Fluorescence was monitored at an excitation wavelength of 355 nm, and emission wavelengths of 400 nm and 490 nm.
[Ca2+]1 was determined by the method of Grynkiewicz et al. [20] . The results were expressed as the maximum change in 
Analysis of cellular F-actin content
The cellular content of polymerized actin (F-actin) was determined by staining of fixed U937 cells with the fluorescent Factin stain NBD-phallacidin, as previously described [17] . The stained cells were analysed on an Epics Profile fluorescence activated cell sorter (Coulter Electronics). The mean fluorescence intensity per cell was used as a measure of the F-actin content per cell.
[3H]Thymidine incorporation
The growth of U937 cells was arrested by culture (1 x 105 cells/ml) in serum-free RPMI-1640 medium, containing 1 mg/ml BSA and 1.5 mM L-glutamine for 48 h. The cells were then harvested and resuspended in the serum-free RPMI medium. Cell samples (1 ml; 1.5 x 105 cells/ml) were plated into 24-well plates (Linbro). Cells were exposed to vehicle, the various forms of thrombin, TRP or 10 % FCS for 48 h. After 46 h, the level of thymidine incorporation was assessed by a 2 h pulse of [3H]thymidine (1 ,uCi/ml). The cells were collected, pelleted by centrifugation at 12000 g (MSE Micro-Centaur) for 90 s, washed with 2 x 1 ml of PBS and then lysed with 1 ml of 10 % (w/v) trichloroacetic acid for 1 h at 4 'C. The trichloroacetic acid-precipitated material was collected following centrifugation at 15 000 g for 5 min at 4 'C, subjected to 2 x 1 ml washes with ethanol/ether (1:1, v/v) and solubilized with 1 (Figures 1 and 2 ) and human platelets (Table 1) . In platelets, the threshold concentration evoking a significant rise in [Ca2]1 was 50 nM, with the EC50 being 1.18 +0.98,M. This value is similar to the EC50 values previously quoted for TRPmediated activation of platelets [12] . In contrast, in U937 cells > 5 #uM-TRP was required to stimulate a significant increase in [Ca2+]i, with the EC50 for this response being 86 + 7 ,uM.
Structure-function studies in platelets with thrombin receptor peptides of various lengths (6-14 amino acids long) have recently elucidated which amino acid residues are essential for platelet activity [12, 14] . These studies have, for example, demonstrated that Phe, Leu and Arg at positions 2, 4 and 5 respectively of the thrombin receptor peptide are essential for activity, with substitution of any one of these resulting in a substantial loss of agonist activity [12, 14] . In contrast, substitution of Asn at position 6 results in little loss of agonist activity [14] . Some of these points illustrating the specificity of the TRP were confirmed in U937 cells (Figure 3 (Figures 1 and 2 (Figures 1 and 2 ) [16, 17] . These TLCK-thrombin concentrations were previously reported to be chemotactic in human blood monocytes [2] . 2 ) and F-actin formation (Figure 4a ) as 500 #M-TRP. Sub- stantially lower concentrations of TRP were required to evoke Factin formation compared with Ca21 mobilization (Figure 1) , with the EC50 value for TRP-mediated F-actin formation being 56 + 27 nM (Figure 4b) . The lack of a requirement for a rise in [Ca2+]1 for TRP-mediated F-actin formation is in line with our earlier study which reported that thrombin stimulated F-actin formation by a signalling pathway independent of Ca2+ mobilization [17] . In contrast to thrombin or TRP, TLCK-thrombin (500 nM) had no significant effect (P > 0.05) on F-actin formation over a 5 min time course (Figure 4c ). for 48 h in serum-free medium and exposed to the various stimuli for 48 h, and [3H]thymidine incorporation was determined in the penultimate 2 h. As shown in Figure 5 , thrombin (10-50 units/ml) caused a concentration-dependent 2-8-fold increase in [3H]- 2 and 4) [16, 17] . Similarly, TRP only had a significant (P < 0.05) mitogenic effect (1.4-fold above resting levels) at > 500 ,uM TRP, which again was considerably higher than the threshold TRP concentration required to stimulate Ca2+ mobilization or F-actin formation (Figures 1, 2 and 4) .
Two synthetic 14-amino-acid peptides (Peptides 1 and 2) based on part of the B-chain of thrombin [3, 4] were examined for their potential mitogenic effects in U937 cells. At concentrations of Peptide 1 (10 nM-10 M) reported to be mitogenic in murine macrophage cell lines [3, 4] , there was no significant (P > 0. 
DISCUSSION
The recent cloning of the thrombin receptor has revealed that thrombin-stimulated responses in platelets, endothelial cells and fibroblasts are mediated by a mechanism dependent upon the proteolytic cleavage of its receptor [6] [7] [8] . The observation that human blood monocytes and various murine macrophage cell lines could be activated by catalytically inactivated forms of thrombin or peptides corresponding to parts of the thrombin Bchain [2] [3] [4] suggested that monocytic cells might possess a second class of thrombin receptor that is activated by a non-proteolytic, hormone-like mechanism. However, in the present study using the thrombin-responsive U937 human monocyte cell line [2, 16, 17] , evidence was obtained solely for a proteolytic mechanism for thrombin cell activation. The inactive thrombin derivatives TLCK-thrombin and PPACK-thrombin had no effect on [Ca2+]1, F-actin formation or cell proliferation in U937 cells, which was clearly different to the responses mediated by native thrombin. Further, a synthetic 14-amino-acid peptide (Peptide 1) corresponding to a part of the B-chain of thrombin, which has been reported to be mitogenic in murine macrophage cell lines [3, 4] , also had no mitogenic effect in U937 cells. Species differences might be invoked as a reason for the difference in effects of the various catalytically inactive forms of thrombin reported in this study using the U937 human monocyte-macrophage cell line (no agonistic effects) and in the earlier studies of Bar-Shavit et al. [3, 4] in murine macrophage cell lines (agonistic effects).
In contrast to the inactive forms of thrombin, the N-terminal thrombin-receptor-derived hexapeptide (TRP; SFLLRN) [12, 14] Whether all the cellular actions of thrombin require hydrolysis of its receptor remains to be established. In macrophage cells of murine origin [3, 4] the possibility was considered of other thrombin receptor subtypes which do not require the serine proteinase activity ofthrombin for cell activation. This possibility has, however, been ruled out in the present study using U937 human monocyte/macrophages, and to date (with one exception) all of the cellular actions of thrombin have been shown to be mimicked by synthetic 5-14-amino-acid peptides corresponding to a part of the newly created N-terminal domain of the cleaved thrombin receptor [6] [7] [8] [9] [10] [11] [12] [13] [14] . The one exception was a study by Vouret-Craviari et al. [9] , who demonstrated that thrombinreceptor-derived peptides failed to mimic the mitogenic effect of thrombin in CCL39 hamster fibroblasts. These workers suggested that the mitogenic action of thrombin in CCL39 cells might be mediated by another class of thrombin receptor, one that is not activated by thrombin-receptor-derived peptides. However, Huang et al. [11] have more recently reported mitogenic effects of thrombin-receptor-derived peptides in CCL39 cells. The present study has also shown that TRP mimics the mitogenic effect of thrombin in U937 cells, though for both thrombin and TRP considerably higher concentrations were required to stimulate a threshold mitogenic response relative to other U937 cell responses.
In an earlier study from this laboratory, we reported differences in the behaviour of thrombin with U937 cells relative to human platelets [16] . In U937 cells, though not in platelets, thrombin failed to stimulate thromboxane B2 synthesis or to inhibit adenylate cyclase. Additionally, concentration-response curves for Ca2+ mobilization in the two cell systems revealed that the thrombin concentration required to evoke a threshold response in U937 cells was -20-fold higher than in platelets. Interestingly, in the present study, differences in the concentration-response curves for TRP-stimulated Ca2+ mobilization in platelets and U937 cells were also evident, e.g. the threshold TRP concentration was > 100-fold greater in U937 cells compared with platelets. While the differences between U937 cells and platelets reported here and elsewhere [16] with respect to the effects of thrombin and TRP do not provide evidence that thrombin receptor subtypes exist, it is tempting to speculate that U937 cells possess a subtype of the platelet thrombin receptor which is also a substrate for thrombin serine proteinase activity, but at which the newly revealed N-terminus ligand has lower affinity for the receptor. This possibility, however, requires further examination.
